CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
391-405 of 1187
Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis
MinuteCE®Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis
Arun B. Jesudian, MD
Nancy S. Reau, MD
Minimal Hepatic Encephalopathy: Hiding in Plain Sight?
MinuteCE®Minimal Hepatic Encephalopathy: Hiding in Plain Sight?
Arun B. Jesudian, MD
Nancy S. Reau, MD
Hepatic Encephalopathy: More Common Than You Think
MinuteCE®Hepatic Encephalopathy: More Common Than You Think
Arun B. Jesudian, MD
Minimal Hepatic Encephalopathy: A Covert Operation?
MinuteCE®Minimal Hepatic Encephalopathy: A Covert Operation?
Nancy S. Reau, MD
Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy
MinuteCE®Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy
Nancy S. Reau, MD
Advances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
CME/CE Broadcast ReplayAdvances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
Michael T. Collins, MD
- advertisement
Inside the Cataracts Studio: Advanced Fluidics, Ergonomics, and Techniques for Complex Cases - Introducing Robotic SLACS
CME/CEInside the Cataracts Studio: Advanced Fluidics, Ergonomics, and Techniques for Complex Cases - Introducing Robotic SLACS
Wendell J. Scott, MD
Taking Action Against RSV: No Child Unprotected
CME/CETaking Action Against RSV: No Child Unprotected
Tina Q. Tan, MD
Yvonne Maldonado, MD
The Future of Oral SERDs: Combination Strategies
MinuteCE®The Future of Oral SERDs: Combination Strategies
Komal Jhaveri, MD, FACP
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
MinuteCE®Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
Giuseppe Curigliano, MD, PhD
Future-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
CME/CEFuture-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
Marc A. Riedl, MD, MS
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
MinuteCE®Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
Komal Jhaveri, MD, FACP
- advertisement
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
MinuteCE®Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Rethinking Schizophrenia Treatment Through Muscarinic Modulation
CME/CERethinking Schizophrenia Treatment Through Muscarinic Modulation
Jose M. Rubio, MD, PhD
Jonathan M. Meyer
Cynthia Villarreal-Garza, MD, DSc
